文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肠道菌群决定 T 细胞克隆选择以增强干细胞移植后的移植物抗宿主病。

Microbiota dictate T cell clonal selection to augment graft-versus-host disease after stem cell transplantation.

机构信息

Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.

Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.

出版信息

Immunity. 2024 Jul 9;57(7):1648-1664.e9. doi: 10.1016/j.immuni.2024.05.018. Epub 2024 Jun 13.


DOI:10.1016/j.immuni.2024.05.018
PMID:38876098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11236519/
Abstract

Allogeneic T cell expansion is the primary determinant of graft-versus-host disease (GVHD), and current dogma dictates that this is driven by histocompatibility antigen disparities between donor and recipient. This paradigm represents a closed genetic system within which donor T cells interact with peptide-major histocompatibility complexes (MHCs), though clonal interrogation remains challenging due to the sparseness of the T cell repertoire. We developed a Bayesian model using donor and recipient T cell receptor (TCR) frequencies in murine stem cell transplant systems to define limited common expansion of T cell clones across genetically identical donor-recipient pairs. A subset of donor CD4 T cell clonotypes differentially expanded in identical recipients and were microbiota dependent. Microbiota-specific T cells augmented GVHD lethality and could target microbial antigens presented by gastrointestinal epithelium during an alloreactive response. The microbiota serves as a source of cognate antigens that contribute to clonotypic T cell expansion and the induction of GVHD independent of donor-recipient genetics.

摘要

同种异体 T 细胞扩增是移植物抗宿主病 (GVHD) 的主要决定因素,目前的主流观点认为,这是由供体和受体之间组织相容性抗原差异驱动的。这种范例代表了一个封闭的遗传系统,其中供体 T 细胞与肽-主要组织相容性复合物 (MHC) 相互作用,尽管由于 T 细胞库的稀疏性,克隆询问仍然具有挑战性。我们使用小鼠干细胞移植系统中的供体和受体 T 细胞受体 (TCR) 频率开发了一个贝叶斯模型,以定义跨越遗传上相同的供体-受体对的 T 细胞克隆的有限共同扩增。供体 CD4 T 细胞克隆型的亚组在相同的受体中差异扩增,并依赖于微生物群。特定于微生物群的 T 细胞增强了 GVHD 的致死性,并可以靶向同种反应期间胃肠道上皮细胞呈递的微生物抗原。微生物群作为同源抗原的来源,有助于克隆型 T 细胞的扩增,并诱导与供体-受体遗传无关的 GVHD。

相似文献

[1]
Microbiota dictate T cell clonal selection to augment graft-versus-host disease after stem cell transplantation.

Immunity. 2024-7-9

[2]
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.

Cochrane Database Syst Rev. 2013-7-23

[3]
The effect of ADAMTS13 on graft-versus-host disease.

J Cell Mol Med. 2024-7

[4]
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.

Cochrane Database Syst Rev. 2012-9-12

[5]
Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.

Front Immunol. 2023

[6]
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.

Cochrane Database Syst Rev. 2024-11-7

[7]
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.

Cochrane Database Syst Rev. 2023-6-21

[8]
Targeting cell-surface VISTA expression on allospecific naïve T cells promotes tolerance.

Blood. 2025-4-10

[9]
Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.

Front Immunol. 2021

[10]
Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model.

Molecules. 2024-4-16

引用本文的文献

[1]
Antibiotic use: impact on the microbiome and cellular therapy outcomes.

Blood Adv. 2025-7-8

[2]
Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect.

Nat Commun. 2025-1-25

[3]
Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions.

Mol Med. 2025-1-3

本文引用的文献

[1]
Mapping the T cell repertoire to a complex gut bacterial community.

Nature. 2023-9

[2]
Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells.

Immunity. 2023-2-14

[3]
The CD4 T cell response to a commensal-derived epitope transitions from a tolerant to an inflammatory state in Crohn's disease.

Immunity. 2022-10-11

[4]
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation.

JCI Insight. 2021-7-8

[5]
Integrated analysis of multimodal single-cell data.

Cell. 2021-6-24

[6]
The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets.

Haematologica. 2021-8-1

[7]
Gut CD4 T cell phenotypes are a continuum molded by microbes, not by T archetypes.

Nat Immunol. 2021-2

[8]
Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant.

Blood Adv. 2020-9-8

[9]
Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases.

Nat Biotechnol. 2021-2

[10]
Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening.

Nat Biotechnol. 2020-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索